Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal

NEW YORK (AP) — Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal.

Copyright © 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Related Categories:

National News

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up